The Pharmacy Times® Flu Resource Center is a comprehensive resource for clinical news and expert insights on the treatment of influenza, a contagious viral infection that can cause mild to severe symptoms and life-threatening complications.
August 29th 2025
FluMist Home, the first at-home nasal spray flu vaccine, is now available for direct delivery to patients in 34 US states.
For the First Time Ever, CDC Makes Specific Recommendations on Flu Vaccines for Geriatric Patients
CDC makes groundbreaking shift by providing influenza vaccination recommendations for the geriatric population.
Read More
CDC and FDA Recommendations for SARS-CoV-2 Booster Shots
Experts in the management of SARS-CoV-2 educate on CDC and FDA recommendations for approaching administration of booster vaccines, including those for special patient populations.
Watch
Defining SARS-CoV-2 Bivalent Vaccines and Optimizing Protection Through Vaccination
Wendy Wright, DNP, ANP-BC, FNP-BC, FAANP, FAAN, FNAP; Jacinda Abdul-Mutakabbir, PharmD; and Rodney E. Rohde, PhD, MS, SM(ASCP)CM, SVCM, MBCM, FACSc; review what encompasses a bivalent vaccine and give their perspective on how to communicate the role of the vaccine in optimizing protection for patients.
Watch
Evolution of SARS-CoV-2 Variants on Booster Shot Development and Formulations
Rodney E. Rohde, PhD, MS, SM(ASCP)CM, SVCM, MBCM, FACSc, leads a discussion on the constant evolution of SARS-CoV-2 variants and the impact on vaccine and booster shot development and administration.
Watch
COVID-19 Booster Vaccination Protection Rates
Jacinda Abdul-Mutakabbir, PharmD; Wendy Wright, DNP, ANP-BC, FNP-BC, FAANP, FAAN, FNAP; and Madeline King, PharmD, BCIDP, examine the efficacy and real-world implications of the COVID-19 booster shot in terms of vaccination protection rates.
Watch
Impact of SARS-CoV-2 Subvariants on Vaccination
Wendy Wright, DNP, ANP-BC, FNP-BC, FAANP, FAAN, FNAP, leads a discussion on the challenges subvariants of SARS-CoV-2 present in terms of vaccination and approaching optimal communication to the public surrounding vaccination.
Watch
Defining Variants of Interest vs Variants of Concern
Expert health professionals share their thoughts on variants of concern vs variants of interest of the SARS-CoV-2 strains as they relate to clinical practice.
Watch
Expert: Long-term Care Industry Needs Help of Pharmacists to Improve Infection Prevention, Control
November 7th 2022A session presenter at the ASCP 2022 Annual Meeting explained how the COVID-19 pandemic significantly magnified the importance of infection prevention and control practices in long-term care.
Read More
Overview of SARS-CoV-2 Virus and Subvariants
Jacinda Abdul-Mutakabbir, PharmD, discusses the difference between the original SARS-CoV-2 strain and subvariant strains.
Watch